Trials / Completed
CompletedNCT01640717
A Retrospective, Observational, Noninterventional Data Collection Study for Patients With Molybdenum Cofactor Deficiency Who Have Been Previously Treated With Cyclic Pyranopterin Monophosphate (cPMP)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Origin Biosciences · Industry
- Sex
- All
- Age
- 1 Day
- Healthy volunteers
- Not accepted
Summary
The primary objective is to assess safety and efficacy data of Escherichia coli-derived cPMP in patients with molybdenum cofactor deficiency (MoCD).
Conditions
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2012-07-16
- Last updated
- 2019-03-19
Locations
13 sites across 6 countries: United States, Australia, Germany, Netherlands, Turkey (Türkiye), United Kingdom
Source: ClinicalTrials.gov record NCT01640717. Inclusion in this directory is not an endorsement.